Manufacturing of viral vector at scale presents two main challenges that can jeopardize meeting regulatory compliance:
- The sourcing of raw materials
- The management of the supply chain.
Having unlimited access to high quality raw and starting materials, such as transfection reagent, cell lines, media components, growth factors, serum, consumables and excipients is crucial.
Our experts Natalia Elizalde Urdiain, Business Development Director at VIVEbiotech, Filipe Cristóvão, Head of USP Development Department at VIVEbiotech, and Julien DEPOLLIER Ph.D., Strategic partnership Director at Polyplus have talked about how to overcome these current challenges.
Thank you very much to Polyplus for this unique opportunity!
You can read the resulting article here: https://www.polyplus-transfection.com/blog/successful-lentiviral-vector-manufacturing/